Pilot Study to Determine Feasibility of Benign and Malignant Skin Lesion Detection.
NCT02009085 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 126
Last updated 2018-02-19
Summary
In this study a fluorescent contrast dye is applied to a suspicious skin lesion.
Images are acquired and processed. The information is used to develop a prediction model for the presence of malignant transformation in the skin.
Conditions
- Skin Lesions
Sponsors & Collaborators
-
Clalit Health Services
collaborator OTHER -
Orlucent, Inc
lead INDUSTRY
Principal Investigators
-
Yehuda Ullmann, MD · Rambam Health Care Campus
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-06-30
- Primary Completion
- 2017-06-30
- Completion
- 2017-06-30
More Related Trials
-
Use of Fiber-optic Probe for Non-invasive Diagnosis of Melanoma and Assessment of Impact of Ultraviolet (UV) Exposure on Skin
NCT01085396 ·Status: TERMINATED
-
Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by Surgery
NCT01886235 ·Status: COMPLETED ·Phase: NA
-
The Use of Mole Mapping Diagrams to Increase Skin Self Examination Accuracy
NCT00237965 ·Status: COMPLETED ·Phase: NA
-
Intravital Microscopy in Identifying Tumor Vessels in Patients With Stage IB-IIIC Melanoma Undergoing Sentinel Lymph Node Biopsy
NCT02857374 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging
NCT02056522 ·Status: COMPLETED
-
Early Diagnosis of Malignant Transformation of Pigmentary Skin Lesions
NCT01167998 ·Status: UNKNOWN
-
A Pilot Study to Evaluate Optical Spectroscopy of Pigmented Skin Lesions
NCT00633516 ·Status: COMPLETED
-
Educational Program in Skin Self-Examination To Detect Melanoma in Healthy Participants
NCT00416988 ·Status: COMPLETED ·Phase: NA
-
Moletest Clinical Study in Scotland
NCT02196246 ·Status: COMPLETED
-
Imaging Methods for the Diagnosis of Non-melanoma Skin Cancer and Its Precursors
NCT05842421 ·Status: COMPLETED ·Phase: NA
-
Investigating the Clinical Utility of the MDS
NCT03109327 ·Status: COMPLETED
-
Diagnostic Precision of the AI Tool Dermalyzer to Identify Malignant Melanomas in Subjects Seeking Primary Care for Melanoma-suspected Cutaneous Lesions
NCT05172232 ·Status: COMPLETED
-
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
NCT00040352 ·Status: RECRUITING
-
Photodynamic Therapy for Lentigo Maligna Using 5-aminolevulinic Acid Nanoemulsion as a Light Sensitizing Cream
NCT02685592 ·Status: COMPLETED ·Phase: PHASE4
-
Intratumoral Administration of L19IL2/L19TNF
NCT02076633 ·Status: COMPLETED ·Phase: PHASE2
-
Confocal Microscopy of Benign and Malignant Skin Tumors
NCT01010321 ·Status: SUSPENDED
-
MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma
NCT03699995 ·Status: TERMINATED ·Phase: NA
-
In-vivo Optical Coherence Tomography Imaging in Dermatooncology
NCT01680562 ·Status: UNKNOWN
-
DermTech's Non-Invasive Pigmented Lesion Assay to Detect and Track Lesions for Suspected Melanoma and to Determine Outcomes for up to 2 Years
NCT04563949 ·Status: COMPLETED
-
Study of PI-88 in Patients With Advanced Melanoma
NCT00068172 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Tracing Dissemination of Melanoma Cells in Healthy Tissues
NCT02854124 ·Status: COMPLETED
-
Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions
NCT07213154 ·Status: RECRUITING ·Phase: NA
-
IL-2 "SELECT" Tissue Collection Protocol in Patients With Advanced Melanoma
NCT01288963 ·Status: COMPLETED
-
Mohs and Immunofluorescence for Malignant Melanoma In Situ
NCT02306512 ·Status: WITHDRAWN ·Phase: NA
-
Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma
NCT03725449 ·Status: COMPLETED ·Phase: NA